rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    BOLT
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Bolt Biotherapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
      Nov 12Yahoo FinanceBOLT
      Coastlands Capital LP buys $319,000 in Bolt Biotherapeutics stock
      Nov 10Investing.comBOLT
      Bolt Biotherapeutics to Participate in Upcoming Conferences
      Nov 3Yahoo FinanceBOLT
      $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT)
      Oct 26MorningstarBOLT
      12 Health Care Stocks Moving In Friday's Intraday Session
      Oct 23BenzingaBOLTLUCD
      Bolt Biotherapeutics acquires Prana in reverse merger deal
      Oct 23Investing.comBOLT
      Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications
      Oct 23Yahoo FinanceBOLT
      Bolt Biotherapeutics CEO Quinn sells $58,402 in stock
      Sep 22Investing.comBOLT
      Bolt Biotherapeutics senior VP Nemec sells $26,072 in shares
      Sep 22Investing.comBOLT
      Bolt Biotherapeutics COO Grant Yonehiro sells $43,806 in company shares
      Sep 22Investing.comBOLT
      Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

      Initial clinical data for BDC-4182 Phase 1 dose escalation study expected in 3Q 2026  Cash balance of $38.8 million as of September 30, 2025 anticipated to...

      Aug 31BarchartBOLT

      This is the newest page. Registered accounts read further back.